AcuCort AB jobs and careers
As of October 23, 2026, AcuCort AB has no open roles listed.
About AcuCort AB
AcuCort has developed and commercializes Zeqmelit™, a new fast-dissolving oral film to put on the tongue, based on the well-known cortisone substance dexamethasone. The drug is a smart product in a new, innovative, patented, and user-friendly dosage form primarily for the treatment of severe and acute allergic reactions, croup in children and chemotherapy-induced nausea and vomiting (CINV) and for the treatment of patients with COVID-19 who need supplemental oxygen therapy. Zeqmelit™ is approved in Sweden, Denmark, and Norway; and AcuCort has signed its first commercial agreement. Altogether, this strengthens the company’s assessment that the time to commercialization may be relatively short. AcuCort (ticker: ACUC) is listed on the Spotlight Stock Market in Sweden. Please visit www.acucort.se.
- Employees
- 1 to 10
Leadership
The top of AcuCort AB's org chart, with how many people report into each leader.
Jonas Jönmark
Chief Executive Officer
Jobs at AcuCort AB
No open positions right now. Explore more companies on TheJobsMap.
AcuCort AB jobs: common questions
- Is AcuCort AB hiring right now?
- AcuCort AB has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on AcuCort AB's careers site.
- Who leads AcuCort AB?
- Jonas Jönmark, Chief Executive Officer, is at the top of AcuCort AB's org chart.
- How do I apply for a job at AcuCort AB?
- Pick a role on AcuCort AB's TheJobsMap page and select Apply. Every listing links to the original posting on AcuCort AB's own careers site, so you apply directly with the employer.